Gender Differences in Hypertension

This activity will consist of three lectures by experts in the field of blood pressure. These lectures will improve the audience’s understanding of how gender affects blood pressure regulation in both normal and abnormal states, and how the pathophysiology of hypertension changes in women with age. The final talk will provide evidence with regard to whether treatment of hypertension should differ among men and women. Faculty will also review the existing literature and provide an update on recent studies.

Target Audience

  • Physicians 
Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; complete the pre-test; review the video content; complete the post-test (minimum score of 70% required; learners will only have 3 attempts to pass the post-test) and evaluation to successfully earn credit.  

If you participated in the live symposium Gender Differences in Hypertension on April 12, 2018 and claimed credit, you should not claim credit for this endured activity.

Learning Objectives

After participation in this activity, learners will be better able to:

  • Describe how the pathophysiology of hypertension changes over the course of a woman's life 
  • Express how differences in biological / hormonal systems in men and women affect blood pressure
  • Discuss whether the management of hypertension should be different for men versus women
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
Course opens: 
Course expires: 
Faculty Disclosures:

Nanette Wenger, MD, MACC, MACP, FAHA
Professor of Medicine
Emory University School of Medicine
Atlanta, GA
Disclosure: Has no financial relationships with commercial interest(s).

Suzanne Oparil, MD
Distinguished Professor of Medicine, Vascular Biology & Hypertension Program Director
University of Alabama at Birmingham
Birmingham, AL
Disclosure: Has no financial relationships with commercial interest(s).

Jennifer Sullivan, PhD
Associate Professor
Augusta University
Augusta, GA
Disclosure: Has no financial relationships with commercial interest(s).

Planning Committee Disclosures:

Lawrence Weisberg, MD, FNKF
Professor of Medicine, Chief of Nephrology
Cooper University Health Care, Cooper Medical School of Rowan University
Camden, NJ
Disclosure: Consulting Fee: PLC Medical, Inc.

Tara Chang, MD, MS 
Stanford University 
Assistant Professor of Medicine
Disclosure: Consulting Fee: Jansse, Consulting Fee: Fresenius

Danielle Nathan, MA
Senior Director, Professional Education
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Kathryn Troy, MPH
Professional Education Manager
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.


In support of improving patient care, the National Kidney Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


The National Kidney Foundation designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance


Please login or register for a PERC account to take this course.

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Required Hardware/software

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit

For additional professional education resources, contact NKF at 1-800-622-9010 or visit